Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

VPNA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 23
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

PADAGIS US

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 24
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

EPIC PHARMA LLC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 29
  • 0 comments

FDA approve NABUMETONE

Comment Full text

ANI PHARMS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 22
  • 0 comments

FDA approve ETODOLAC

Comment Full text

STEVENS J

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 26
  • 0 comments

FDA approve ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE

Comment Full text

SANDOZ

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 23
  • 0 comments

FDA approve ETODOLAC

Comment Full text

ACTAVIS ELIZABETH

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 25
  • 0 comments

FDA approve ETODOLAC

Comment Full text

APOTEX INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 24
  • 0 comments

FDA approve KETOROLAC TROMETHAMINE

Comment Full text

DR REDDYS LABS INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 20
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

TARO

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 21
  • 0 comments

FDA approve ETODOLAC

Comment Full text
  • Previous
  • 201
  • 202
  • 203
  • 204
  • 205
  • Next

Search

News categories

  • Technical Exchange News(9888)
  • Event(407)
  • SEC News(167424)
  • FDA Approval(9345)
  • Company Report(721)
  • Business News(111262)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin